Ikonisys: Funding, Investors & Team (Oct 2026)
Ikonisys is revolutionizing the field of diagnostic medicine by facilitating the early and precise identification of diseases in a non-invasive manner. By utilizing a specialized blend of technology and scientific expertise, Ikonisys is committed to assisting doctors and researchers in harnessing the potential of detecting rare cells, ultimately offering patients the highest probability of effectively managing their diseases.
Ikonisys has raised $540k across 1 funding round on record, the most recent an undisclosed round of $540k announced in Jun 2023.
That round is below the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Ikonisys Company Profile and Key Stats
Latest funding round on record: Jun 2023.
Ikonisys Funding Rounds
Ikonisys Founders and Leadership Team
Contact details for the Ikonisys team: 1 of 1 has an email address on file.
Start 14-day free trial →Ikonisys Funding Compared to Other Biotechnology Startups
Ikonisys' latest round of $540k is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Ikonisys in Biotechnology and New Haven
Companies Similar to Ikonisys
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…
Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…
Ikonisys Funding FAQs
What does Ikonisys do?
Ikonisys is revolutionizing the field of diagnostic medicine by facilitating the early and precise identification of diseases in a non-invasive manner. By utilizing a specialized blend of technology and scientific expertise, Ikonisys is committed to assisting doctors and researchers in harnessing the potential of detecting rare cells, ultimately offering patients the highest probability of effectively managing their diseases.
How much funding has Ikonisys raised?
Ikonisys has raised $540k across 1 round on record. The most recent is an undisclosed round of $540k announced in Jun 2023.
When did Ikonisys last raise funding?
Ikonisys' most recent funding round on record is an undisclosed round of $540k, announced in Jun 2023.
Who founded Ikonisys?
FundedIQ lists Michael Kilpatrick (Founder) at Ikonisys.
Where is Ikonisys headquartered?
Ikonisys is based in New Haven, Connecticut, United States.
How many employees does Ikonisys have?
Ikonisys is in the 51-100 employee band.
How does Ikonisys' funding compare to other Biotechnology startups?
Ikonisys' latest round of $540k is below the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Ikonisys Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Ikonisys is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.